Meliha Brankov

Author PubWeight™ 8.39^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Recombinant adeno-associated virus type 2-mediated gene delivery into the Rpe65-/- knockout mouse eye results in limited rescue.	Genet Vaccines Ther	2004	1.47
2	Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys.	Mol Ther	2005	1.19
3	Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA.	Exp Eye Res	2002	0.90
4	Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide.	Exp Eye Res	2004	0.87
5	Correlation between inactive cathepsin D expression and retinal changes in mcd2/mcd2 transgenic mice.	Invest Ophthalmol Vis Sci	2005	0.84
6	Enhanced recombinant adeno-associated virus-mediated vascular endothelial growth factor expression in the adult mouse retina: a potential model for diabetic retinopathy.	Diabetes	2003	0.82
7	rAAV.sFlt-1 gene therapy achieves lasting reversal of retinal neovascularization in the absence of a strong immune response to the viral vector.	Invest Ophthalmol Vis Sci	2009	0.82
8	Virus-mediated secretion gene therapy--a potential treatment for ocular neovascularization.	Adv Exp Med Biol	2003	0.78
9	Assessment of rAAV-mediated gene therapy in the Rpe65-/- mouse.	Adv Exp Med Biol	2003	0.76
10	Discovery of a novel control element within the 5'-untranslated region of the vascular endothelial growth factor. Regulation of expression using sense oligonucleotides.	J Biol Chem	2004	0.75